Tempest Therapeutics files updated corporate presentation; no specific new data disclosed in filing.

Tempest Therapeutics, Inc.

Company posted February 2026 investor presentation on its website.
Presentation title: 'Accelerating the Development of Advanced Therapies for Cancer Patients'.
No financial or clinical trial results were included in the 8-K filing.
Investors should refer to the full presentation on the company's website for details.

item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-26-045543
form_type: 8-K
ticker: TPST
cik: 0001544227
company_name: Tempest Therapeutics, Inc.
filed_at: 2026-02-11T23:59:59+00:00
discovered_at: 2026-05-14T18:02:35.390235+00:00
generated_at: 2026-05-16T03:17:58.857076+00:00
sec_items: ["7.01", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.2
confidence: low
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-26-045543
json_url: https://secwatch.observer/filing/0001193125-26-045543.json
markdown_url: https://secwatch.observer/filing/0001193125-26-045543.md
text_url: https://secwatch.observer/filing/0001193125-26-045543.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1544227/000119312526045543/0001193125-26-045543-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1544227/000119312526045543/d47566d8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001193125-26-045543

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.